SCHEMBL30134451

SCHEMBL30134451

CNC(=O)c1cc(OC)cc2cccnc12

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 8/20 0.58
MEN1 O00255 7/20 0.57
ALDH1A1 P00352 3/20 0.54
EGLN1 Q9GZT9 3/20 0.54
HTT P42858 1/20 0.51
HDAC1 Q13547 1/20 0.51
HDAC6 Q9UBN7 1/20 0.51
MAPT P10636 3/20 0.50
TP53 P04637 2/20 0.50
HPGD P15428 2/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
HSD17B10 Q99714 1/20 0.50
MTNR1A P48039 1/20 0.50
TDP1 Q9NUW8 3/20 0.49
SLC40A1 Q9NP59 1/20 0.49
KDM4E B2RXH2 2/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
POLB P06746 1/20 0.47
LMNA P02545 1/20 0.47
TSHR P16473 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29923746 0.86 KMT2A (0.56) KMT2AMEN1ALDH1A1EGLN1HTT
SCHEMBL11804278 0.84 NSD2 (0.58) KMT2AMEN1ALDH1A1EGLN1HTT
SCHEMBL29923896 0.83 ALDH1A1 (0.55) KMT2AMEN1ALDH1A1EGLN1HTT
SCHEMBL29923698 0.83 PARP1 (0.58) KMT2AMEN1ALDH1A1EGLN1HTT
SCHEMBL20515224 0.83 PARP1 (0.58) KMT2AMEN1ALDH1A1EGLN1HTT
SCHEMBL29923828 0.81 ALDH1A1 (0.53) KMT2AMEN1ALDH1A1EGLN1HTT
SCHEMBL29923665 0.81 KMT2A (0.52) KMT2AMEN1ALDH1A1EGLN1HTT
SCHEMBL29923608 0.80 KMT2A (0.50) KMT2AMEN1ALDH1A1EGLN1HTT
SCHEMBL29923860 0.78 PARP1 (0.49) KMT2AMEN1EGLN1MAPTTDP1
SCHEMBL8402853 0.77 NPC1 (0.64) KMT2AMEN1ALDH1A1MAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230026466-A1 WDR5 INHIBITORS AND MODULATORS VANDERBILT UNIVERSITY 2023-01-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230026466-A1 WDR5 INHIBITORS AND MODULATORS WDR5, WDR1, WDR3 KMT2A 641/4885MEN1 2706/4885ALDH1A1 3815/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.